太极集团: 太极集团关于子公司补缴税款的公告

Core Viewpoint - The company announced that its subsidiaries, Southwest Pharmaceutical Co., Ltd. and Chongqing Chinese Herbal Medicine Co., Ltd., are required to pay a total of approximately 100 million yuan in back taxes and late fees due to tax inspections and self-assessments [1] Group 1: Tax Payment Details - Southwest Pharmaceutical is required to pay approximately 80 million yuan in income tax [1] - Chongqing Chinese Herbal Medicine needs to pay about 20 million yuan in value-added tax and late fees [1] - The total amount due will be recorded in the company's 2024 financial results [1] Group 2: Financial Impact - The payment of back taxes and late fees is expected to reduce the company's net profit attributable to shareholders by 100 million yuan in 2024 [2] - This tax payment does not involve any administrative penalties and will not require adjustments to prior financial statements [2] Group 3: Management Response - The company's management is taking the matter seriously and plans to enhance supervision and management of its subsidiaries [2] - There will be an emphasis on training and awareness regarding tax responsibilities to protect the interests of the company and its shareholders [2]